This study examines the ability of osteoprotegerin (OPG) to prevent the local bone resorption
caused by sciatic nerve damage. Sixty‐five 18‐week‐old male mice were assigned to one of …

The influence of osteoprotegerin (OPG) treatment on callus formation, callus tissue structural
strength, apparent material properties, and histology of tibia fractures in rats was …

RANKL is an essential mediator of bone resorption, and its activity is inhibited by
osteoprotegerin (OPG). Transgenic (Tg) rats were engineered to continuously overexpress …

Osteoprotegerin (OPG) is a naturally secreted protein that decreases bone resorption by
inhibiting osteoclast differentiation and activation while promoting osteoclast apoptosis [8]. In …

Skeletal unloading resulting from space flight and prolonged immobilization causes bone
loss. Such bone loss ostensibly results from a rapid increase in bone resorption and …

Osteoprotegerin (OPG) is a recently discovered protein related to the tumor necrosis factor
receptor family. It has been shown to inhibit ovariectomy (ovx)-induced resorption in rats and …

Osteoprotegerin (OPG) is a novel secreted glycoprotein of the tumor necrosis factor (TNF)
receptor superfamily that acts as an antiresorptive agent inhibiting osteoclast maturation …

Osteoprotegerin (OPG) is a naturally occurring negative regulator of osteoclast
differentiation, activation, and survival. We created a recombinant form of human OPG …

This study analyzed the temporal and regional variations in bone loss and explored bone
cell activities via biochemical markers during an extended follow-up in patients with spinal …

Rat models of immobilization-induced osteopenia are characterized by uncoupling of bone
metabolism, ie, increased bone resorption and decreased bone formation in trabecular …